Advertisement
IRLAB Therapeutics AB (publ) (IRLAB-A.ST)
Stockholm - Stockholm Real Time Price. Currency in SEK
Follow
As of 01:24PM CET. Market open.
| Previous Close | 13.10 |
| Open | 13.10 |
| Bid | 12.90 x 0 |
| Ask | 13.05 x 0 |
| Day's Range | 12.80 - 13.30 |
| 52 Week Range | 5.58 - 20.20 |
| Volume | |
| Avg. Volume | 26,018 |
| Market Cap | 676.883M |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.18 |
| Earnings Date | Feb 14, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 56.07 |
ACCESSWIREIRLAB to Present at Redeye Technology & Life Science Day on December 3, 2024
GOTHENBURG, SE / ACCESSWIRE / November 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 27, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...
- ACCESSWIRE
Nomination Committee Appointed for IRLAB's Annual General Meeting 2025
IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that the nomination committee ahead of the annual general meeting (AGM) 2025 has been appointed. According to ...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.